| Bisphosphonate group (n= 42) | Bisphosphonate + statin group (n= 35) | P-value (Student's t-test) |
---|---|---|---|
Age, years | 66.4 ± 6.2 (49.3, 77.6) | 65.3 ± 6.8 (52, 76.8) | 0.463 |
Sex | Â | Â | Â |
Male | 2 | 0 | Â |
Female | 40 | 35 | Â |
59 > | 3 | 8 | Â |
60-69 | 24 | 17 | Â |
70 < | 13 | 10 | Â |
Disease duration, years | 24.9 ± 10.6 (6.1, 54.3) | 20.8 ± 8.9 (5.9, 38.) | 0.083 |
Bisphosphonates | Â | Â | Â |
Alendronate | 31 | 26 | Â |
Etidronate | 4 | 5 | Â |
Risedronate | 7 | 4 | Â |
Administered | Â | Â | Â |
> 4 years | 29 | 22 | Â |
1 to 4 years | 13 | 13 | Â |
Prednisolone, mg | 2.4 ± 2.0 (0, 6.0) | 2.8 ± 2.1 (0, 7.0) | 0.355 |
+ | 30 | 28 | Â |
- | 12 | 7 | Â |
Methotrexate, mg | 5.2 ± 3.2 (0, 10) | 4.1 ± 3.1 (0, 10) | 0.140 |
+ | 34 | 25 | Â |
- | 8 | 10 | Â |
Vitamin D 3 , μg | 0.5 | 0.5 |  |
+ | 7 | 3 | Â |
- | 35 | 32 | Â |